Science Explorer Back to mapMap
Discussion
Topic · Surgery

Urinary and Genital Oncology Studies

Urinary and Genital Oncology Studies is a research topic within Surgery. Science Explorer counts 25k research works in it since 1950. 10.2% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the clinical and pathological aspects of urachal carcinoma, including its diagnosis, management, and molecular characteristics. It also covers related topics such as primary urethral carcinoma, nephrogenic adenoma, bladder diverticulum, and immunohistochemical markers for differential diagnosis.

  • Urachal Carcinoma
  • Primary Urethral Carcinoma
  • Nephrogenic Adenoma
  • Bladder Diverticulum
  • Immunohistochemical Markers
  • Bartholin Gland Cyst
  • Urethral Diverticulum
  • Clear Cell Adenocarcinoma
  • Metastatic Tumors
  • Urothelial Origin
Research works
25k
fractional, since 1950
In the world top 10%
2.6k
per year above
Top-10% rate
10.2%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+2%
the tick is no change
Largest producer
United States
30% of the 10 largest, 2022-now
Urinary and Genital Oncology Studies

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Urinary and Genital Oncology Studies research?

By volume, the United States and China publish the most (881 and 606 works in 2022-now).

By volume, 2022-now

  1. 1 United States 881 works
  2. 2 China 606 works
  3. 3 India 342 works
  4. 4 Japan 294 works
  5. 5 Germany 196 works
  6. 6 Italy 169 works
  7. 7 United Kingdom 150 works
  8. 8 France 116 works
  9. 9 Türkiye 110 works
  10. 10 Spain 100 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 29.7%China: 20.5%India: 11.5%Japan: 9.9%6 others listed: 28.3%30%largest
United States881 · 29.7%China606 · 20.5%India342 · 11.5%Japan294 · 9.9%6 others listed840 · 28.3%

Shares of the rows listed above, not of the whole node.

Which institutions lead Urinary and Genital Oncology Studies research?

By volume in 2022-now, All India Institute of Medical Sciences publishes the most Urinary and Genital Oncology Studies research, followed by Peking University and Harvard University.

By volume, 2022-now

  1. 1 All India Institute of Medical SciencesIndia 40 works
  2. 2 Peking UniversityChina 32 works
  3. 3 Harvard UniversityUnited States 31 works
  4. 4 Sichuan UniversityChina 30 works
  5. 5 Mayo ClinicUnited States 27 works
  6. 6 The University of Texas MD Anderson Cancer CenterUnited States 24 works
  7. 7 Sun Yat-sen UniversityChina 24 works
  8. 8 Shanghai Jiao Tong UniversityChina 21 works
  9. 9 Memorial Sloan Kettering Cancer CenterUnited States 20 works
  10. 10 Johns Hopkins UniversityUnited States 18 works

Who are the leading researchers in Urinary and Genital Oncology Studies?

The most-cited researchers publishing on Urinary and Genital Oncology Studies include Ahmedin Jemal, Freddie Bray and Bert Vogelstein.

  1. 1 Ahmedin Jemal United States 761k citations
  2. 2 Freddie Bray France 550k citations
  3. 3 Bert Vogelstein United States 373k citations
  4. 4 Gad A. Getz United States 364k citations
  5. 5 Jun Wang China 340k citations
  6. 6 Carlo La Vecchia Italy 258k citations
  7. 7 Kenneth W. Kinzler United States 253k citations
  8. 8 Roger Chou United States 248k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Urinary and Genital Oncology Studies?

The most cited paper in Urinary and Genital Oncology Studies is "TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells" (Sanjeev Mariathasan et al., 2018), with 5,718 citations. Next come "Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients" (3,563) and "The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours" (3,191).

Most cited papers
#PaperReleasedCitations
1 TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells Sanjeev Mariathasan et al. · Nature Open access Feb 2018 5,718
2 Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients John P. Stein, Gary Lieskovsky, Rick Cote et al. · Journal of Clinical Oncology Feb 2001 3,563
3 The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours Holger Moch, Antonio L. Cubilla, Peter A. Humphrey et al. · European Urology 28 Feb 2016 3,191
4 Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer Herbert Barton Grossman, Ronald B. Natale, Catherine M. Tangen et al. · New England Journal of Medicine Open access 27 Aug 2003 2,691
5 Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends Sébastien Antoni, Jacques Ferlay, Isabelle Soerjomataram et al. · European Urology 29 Jun 2016 2,669
All 100 most cited papers, with filters and sorting

Where is Urinary and Genital Oncology Studies research done?

The largest centres of Urinary and Genital Oncology Studies research in 2022-now are Beijing (China), New York (United States), Tokyo (Japan) and Seoul (South Korea).

Largest cities, 2022-now

  1. 1 BeijingChina 83 works
  2. 2 New YorkUnited States 65 works
  3. 3 TokyoJapan 61 works
  4. 4 SeoulSouth Korea 53 works
  5. 5 ShanghaiChina 52 works
  6. 6 New DelhiIndia 42 works
  7. 7 ChengduChina 40 works
  8. 8 LondonUnited Kingdom 39 works
  9. 9 ParisFrance 39 works
  10. 10 GuangzhouChina 38 works
See Urinary and Genital Oncology Studies on the map

Where is the best place to study Urinary and Genital Oncology Studies?

Among universities, judged by research, Vita-Salute San Raffaele University, University of Iowa and Harvard University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 20.81%fractional works in this field (log) →share of work in the world top 10% →University of IowaVita-Salute San Raff…Sun Yat-sen UniversityHarvard University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Vita-Salute San Raffaele UniversityItaly 71.022.8%23.1×11 +105.5%
2University of IowaUnited States 68.826.2%8.7×16 +162.5%
3Harvard UniversityUnited States 66.316.2%2.6×31 -28.7%
4Sun Yat-sen UniversityChina 63.219.1%3.1×24 +17.2%
5University of Southern CaliforniaUnited States 62.120.4%5.3×16 -6.9%
6Cornell UniversityUnited States 60.522.7%3.6×18 -14.7%
7Peking UniversityChina 60.210.7%4.3×32 +40.8%
8Aarhus UniversityDenmark 59.325.4%3.4×11 +5.0%
9Medical University of ViennaAustria 59.218.9%10.1×12 -6.5%
10Radboud University NijmegenNetherlands 58.825.7%4.0×9 -16.0%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Urinary and Genital Oncology Studies, country by country

Is Urinary and Genital Oncology Studies research growing?

Output in 2022-2025 was 2% higher than in 2018-2021, peaking in 2021. The fastest-growing topics are Urinary and Genital Oncology Studies.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Urinary and Genital Oncology Studies as a percentage of every work published that year, 0.018% in 2024.

still counting0.020%0.040%0.060%Urinary and Genital Oncology Studies0.017% in 202519801990200020102020

Fractional works of Urinary and Genital Oncology Studies over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Urinary and Genital Oncology Studies10.5% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Urinary and Genital Oncology Studies. Posts are plain text and can be reported.